Mark L. Elliott

Follow

Person

Canterbury, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Monoamine reuptake inhibitors for treatment of CNS disorders
- Patent number 6,677,378
- Issue date Jan 13, 2004
- Pfizer Inc.
- Harry R. Howard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phenoxybenzylamine derivatives as SSRIs
- Patent number 6,610,747
- Issue date Aug 26, 2003
- Pfizer Inc.
- Mavis Diane Adam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2,3 disubstituded-4(3H)-quinazolinones
- Patent number 6,303,615
- Issue date Oct 16, 2001
- Pfizer Inc.
- Mark L. Elliott
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Tetralin histamine-3 receptor antagonists
- Publication number 20060094719
- Publication date May 4, 2006
- Pfizer Inc.
- Harry R. Howard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aralkyl and aralkylidene heterocyclic lactam and imides
- Publication number 20050227981
- Publication date Oct 13, 2005
- Pfizer Inc.
- Harry R. Howard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aralkyl and aralkylidene heterocyclic lactam and imides
- Publication number 20050227980
- Publication date Oct 13, 2005
- Pfizer Inc.
- Harry R. Howard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Monoamine reuptake inhibitors for treatment of CNS disorders
- Publication number 20040048856
- Publication date Mar 11, 2004
- Pfizer Inc.
- Harry R. Howard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Phenoxybenzylamine derivatives as SSRls
- Publication number 20030060456
- Publication date Mar 27, 2003
- Mavis Diane Adam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Monoamine reuptake inhibitors for treatment of CNS disorders
- Publication number 20020143003
- Publication date Oct 3, 2002
- Harry R. Howard
- C07 - ORGANIC CHEMISTRY